In This Article:
As the U.S. stock market experiences mixed performance, with key indices such as the Dow Jones showing gains while the S&P 500 and Nasdaq face slight declines, investors are closely evaluating economic indicators and policy announcements for their potential impact on market stability. In this environment of uncertainty, identifying stocks that are undervalued relative to their intrinsic estimates can offer potential opportunities for investors seeking to navigate these turbulent conditions effectively.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
SouthState (NYSE:SSB) | $99.63 | $193.86 | 48.6% |
Argan (NYSE:AGX) | $132.20 | $264.33 | 50% |
MINISO Group Holding (NYSE:MNSO) | $20.69 | $41.15 | 49.7% |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | $30.63 | $59.48 | 48.5% |
Northwest Bancshares (NasdaqGS:NWBI) | $12.40 | $24.55 | 49.5% |
Old National Bancorp (NasdaqGS:ONB) | $23.40 | $45.50 | 48.6% |
Cadre Holdings (NYSE:CDRE) | $33.42 | $65.21 | 48.7% |
Array Technologies (NasdaqGM:ARRY) | $6.86 | $13.50 | 49.2% |
Albemarle (NYSE:ALB) | $77.53 | $151.62 | 48.9% |
DoubleVerify Holdings (NYSE:DV) | $21.59 | $42.15 | 48.8% |
We'll examine a selection from our screener results.
American Healthcare REIT
Overview: American Healthcare REIT, Inc. is a self-managed real estate investment trust specializing in the acquisition, ownership, and operation of a diverse range of clinical healthcare properties such as outpatient medical buildings and senior housing, with a market cap of approximately $4.50 billion.
Operations: The company's revenue segments consist of $137.72 million from outpatient medical buildings, $238.76 million from senior housing operating properties, $52.51 million from triple-net leased properties, and $1.58 billion from integrated senior health campuses.
Estimated Discount To Fair Value: 12.7%
American Healthcare REIT is trading at US$29.72, 12.7% below its estimated fair value of US$34.04, indicating potential undervaluation based on cash flows. Despite a forecasted revenue growth of 9.2% annually and expected profitability in three years, its dividend yield of 3.36% is not well covered by free cash flows. Earnings are projected to grow at an impressive rate of 38.67% per year, although return on equity remains low at a forecasted 3.6%.